In the News

View

The Hill: K Street readies for tax reform fight

Washington’s influence industry sees Speaker John Boehner’s (R-Ohio) designation of tax reform as H.R. 1 as just the latest sign that the issue will be front-and-center this year. Accordingly, lobbyists are ramping up their outreach to Capitol Hill as lawmakers look to roll back tax breaks and lower rates for the first time since 1986.

View More on The Hill

Silverman Praises Healthy Choices Act

The Campaign to End Obesity is applauding legislation introduced by House Ways and Means Committee Democrat Ron Kind that includes a wide range of policies that aim to tackle the obesity epidemic. Kind’s Healthy Choices Act aims to improve prevention and treatment opportunities, increase access to physical activities for adults and children, expand nutrition training and realign transportation policies to promote healthier lifestyle, and support research.

View More

Affordable Care Act Upheld by U. S. Supreme Court

The Supreme Court handed President Obama and the supporters of the Affordable Care Act a significant victory today by finding the issue at the center of the law’s structure — the Individual Mandate — was allowable under the Congress’ taxing powers in the Constitution.  The entire decision can be found here.  Below is a quick summary and initial thoughts.

View More

Real Cause of Current Senate Gridlock

There’s a growing chorus complaining that the Senate is broken, that Republicans are to blame, and that the rules of procedure need to be changed. This argument has any number of flaws, but at its core it relies on a general misrepresentation of how the Senate, and the filibuster in particular, works.

View More

Venn Launches Strategic Partnership in London

VennSquared Communications and Venn Strategies, LLC have  launched a major strategic partnership with Luther Pendragon, the leading independent public affairs and communications firm headquartered in London.  The partnership will serve as a means of providing additional reach for both VennSquared’s and Venn Strategies’ increasing work on behalf of global interests.

View More

The Hill: For every tax break, a lobby to fight for it

Lawmakers will have to cross a minefield laid by K Street in order to achieve the kind of comprehensive tax reform that they envision.

View More on The Hill

Two Top Washington Strategic Consulting Firms Come Together To Launch Venn2 Communications

Stephanie Silverman, CEO of Venn Strategies, and Michael Meehan, president of Blue Line Strategic Communications announce the launch of VennCommunications, a full service communications and public relations company.

View More

Venn Strategies Names Two Senior Staff as Principals

Venn Strategies, LLC, a leading public affairs and government relations firm in Washington, DC, today announced that two members of its senior management team have been made Principals.

View More

Electronic Newsletter of Pharmaceutical Technology: Regulatory Roundup: EMA Outlines Activities for 2011, and More

The European Medicines Agency (EMA) plans to focus on the implementation of its new pharmacovigilance legislation and the pending falsified drug legislation throughout 2011, according to its work program announcement on Feb. 11, 2011.

View More

The Gray Sheet: FDA Long-Term Globalization Strategy Under Development

Coping with an increasingly global device and drug industry will require a paradigm shift that relies less on FDA’s own staff and more on data and resource sharing with other countries, the agency says.

View More

Bloomberg: More Outsourcing Planned for FDA Overseas Factory Inspections

U.S. regulators plan to outsource more inspections of overseas factories within the next decade after criticism from Congress about a lack of oversight for food and drugs made in other countries.

View More on Bloomberg

FDA Webview: 2012 User Fee Legislation Likely to be Bipartisan

Reauthorization of FDA user fees, scheduled for consideration by Congress next year, is expected to pass on a largely bipartisan basis and is unlikely to involve the kind of political controversy currently surrounding the Obama administration’s healthcare legislation.

View More